NO3046901T3 - - Google Patents

Info

Publication number
NO3046901T3
NO3046901T3 NO14845373A NO14845373A NO3046901T3 NO 3046901 T3 NO3046901 T3 NO 3046901T3 NO 14845373 A NO14845373 A NO 14845373A NO 14845373 A NO14845373 A NO 14845373A NO 3046901 T3 NO3046901 T3 NO 3046901T3
Authority
NO
Norway
Application number
NO14845373A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903573A external-priority patent/AU2013903573A0/en
Application filed filed Critical
Publication of NO3046901T3 publication Critical patent/NO3046901T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO14845373A 2013-09-17 2014-09-17 NO3046901T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013903573A AU2013903573A0 (en) 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis
PCT/AU2014/000923 WO2015039173A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis

Publications (1)

Publication Number Publication Date
NO3046901T3 true NO3046901T3 (https=) 2018-03-17

Family

ID=52687998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14845373A NO3046901T3 (https=) 2013-09-17 2014-09-17

Country Status (22)

Country Link
US (1) US9458093B2 (https=)
EP (1) EP3046901B1 (https=)
JP (1) JP6122548B2 (https=)
KR (1) KR101736416B1 (https=)
CN (1) CN105683152B (https=)
AP (1) AP2016009079A0 (https=)
AU (1) AU2014324078B2 (https=)
BR (1) BR112016005601B1 (https=)
CA (1) CA2924356C (https=)
DK (1) DK3046901T3 (https=)
ES (1) ES2655455T3 (https=)
IL (1) IL244621A (https=)
MX (1) MX368865B (https=)
MY (1) MY172557A (https=)
NO (1) NO3046901T3 (https=)
NZ (1) NZ717927A (https=)
PH (1) PH12016500497B1 (https=)
PL (1) PL3046901T3 (https=)
RU (1) RU2635564C2 (https=)
SG (1) SG11201601642WA (https=)
UA (1) UA118111C2 (https=)
WO (1) WO2015039173A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3284981B2 (ja) 1998-11-02 2002-05-27 株式会社デンソー 車両用交流発電機およびそのステータの製造方法
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
JP6734294B2 (ja) * 2015-03-18 2020-08-05 ヴェクタス バイオシステムズ リミテッド 線維症及び線維症に関連する状態の処置のための組成物
DK3271326T3 (da) * 2015-03-18 2021-01-25 Vectus Biosystems Ltd Sammensætninger til behandling af nyre- og/eller leversygdom
CN108349872B (zh) * 2015-09-22 2020-12-18 维克图斯生物系统有限公司 三联苯化合物的合成
US20170296506A1 (en) * 2016-04-13 2017-10-19 Board Of Regents Of The University Of Nebraska Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
MY192402A (en) * 2016-07-28 2022-08-19 Vectus Biosystems Ltd Compositions for the treatment of pulmonary fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694288B1 (fr) * 1992-06-30 1994-09-09 Rhone Poulenc Agrochimie Phenylbenzamides fongicides et procédés pour les préparer.
KR20140057411A (ko) * 2004-06-11 2014-05-12 벡투스 바이오시스템즈 피티와이 리미티드 심혈관 질환의 치료를 위한 조성물 및 방법
AU2006322656B2 (en) * 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
US20120088737A2 (en) * 2009-10-02 2012-04-12 Ajinomoto Co., Inc Novel acyl guanidine derivatives
NZ717930A (en) * 2013-09-17 2018-12-21 Vectus Biosystems Ltd Compositions for the treatment of hypertension and/or fibrosis

Also Published As

Publication number Publication date
IL244621A0 (en) 2016-04-21
MX368865B (es) 2019-08-02
KR20160074471A (ko) 2016-06-28
UA118111C2 (uk) 2018-11-26
EP3046901B1 (en) 2017-10-18
US20160221933A1 (en) 2016-08-04
PH12016500497B1 (en) 2017-12-13
MY172557A (en) 2019-12-02
CA2924356A1 (en) 2015-03-26
RU2016112257A (ru) 2017-10-20
ES2655455T3 (es) 2018-02-20
PH12016500497A1 (en) 2016-06-13
CA2924356C (en) 2018-04-03
WO2015039173A1 (en) 2015-03-26
BR112016005601B1 (pt) 2021-02-02
PL3046901T3 (pl) 2018-03-30
IL244621A (en) 2017-04-30
MX2016003371A (es) 2016-10-21
RU2635564C2 (ru) 2017-11-14
CN105683152B (zh) 2017-03-22
CN105683152A (zh) 2016-06-15
JP6122548B2 (ja) 2017-04-26
AP2016009079A0 (en) 2016-03-31
AU2014324078B2 (en) 2016-12-15
KR101736416B1 (ko) 2017-05-16
BR112016005601A8 (pt) 2020-02-18
EP3046901A4 (en) 2017-04-12
US9458093B2 (en) 2016-10-04
DK3046901T3 (en) 2018-01-02
SG11201601642WA (en) 2016-04-28
JP2016532632A (ja) 2016-10-20
EP3046901A1 (en) 2016-07-27
AU2014324078A1 (en) 2016-04-07
NZ717927A (en) 2018-12-21

Similar Documents

Publication Publication Date Title
AP2016009275A0 (https=)
BR102016010778A2 (https=)
BR112014017733A2 (https=)
BR112014018502A2 (https=)
BR112014017739A2 (https=)
BR112014019326A2 (https=)
BR112014018516A2 (https=)
BR112014018480A2 (https=)
BR112014017855A2 (https=)
BR112014020341A2 (https=)
BR112014017765A2 (https=)
BR112014017669A2 (https=)
BR112014021878A2 (https=)
BR112014018468A2 (https=)
BR112014019204A2 (https=)
BR112014017901A2 (https=)
BR112014018207A2 (https=)
BR112015015948A2 (https=)
BR112014017722A2 (https=)
BR112014017653A2 (https=)
BR112014017794A2 (https=)
BR112016013745A2 (https=)
BR112014018578A2 (https=)
BR112014018483A2 (https=)
BR112014017601A2 (https=)